Obligacje TEV
Poniżej znajduje się lista obligacji korporacyjnych TEVA PHARMACEUT. SP.ADR. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 7,00% | 99,25% | 6,75% | 2028-03-01 | 255 K USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5034099Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 6,97% | 100,15% | 7,13% | 2025-01-31 | 425,259 M USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFACTEVA P.FI.NL III 16/46 | 6,06% | 74,12% | 4,10% | 2046-10-01 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88163VAD1TEVA PHARM.FIN. 2036 | 5,84% | 102,62% | 6,15% | 2036-02-01 | 789,428 M USD | 1 000,00 USD | 2 000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTEVA4914602Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 5,84% | 101,25% | 7,13% | 2025-01-31 | 1,255 M USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS219821395TEVA PHARM FINANCE NL II 6% GTD SNR NTS 31/01/2025 EUR100000 | 5,71% | 100,29% | 6,00% | 2025-01-31 | 410,607 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5,59% | 114,76% | 8,13% | 2031-09-15 | 500 M USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88167AAP6TEVA P.F.III 21/27 | 5,51% | 98,16% | 4,75% | 2027-05-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5,44% | 110,63% | 7,88% | 2029-09-15 | 600 M USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88167AAQ4TEVA P.F.III 21/29 | 5,41% | 98,84% | 5,13% | 2029-05-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFABTEVA P.FI.NL III 16/26 | 5,36% | 95,80% | 3,15% | 2026-10-01 | 3,378 B USD | 1 000,00 USD | 2 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5,34% | 104,41% | 6,75% | 2028-03-01 | 1,25 B USD | 1 000,00 USD | 200 000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS259280419TEV.P.F.N.II 23/31 | 4,78% | 118,48% | 7,88% | 2031-09-15 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443TEV.P.F.N.II 23/29 | 4,60% | 112,34% | 7,38% | 2029-09-15 | 800 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS181372460TEVA PH.F.NL.II 18/25 | 4,50% | 100,00% | 4,50% | 2025-03-01 | 494,346 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717TEV.P.F.N.II 21/30 | 4,40% | 99,87% | 4,38% | 2030-05-09 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS143974936TEVA PH.F.NL.II 16/28 | 4,08% | 90,82% | 1,63% | 2028-10-15 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS121104407TEVA PH.F.NL.II 15/27 | 4,06% | 94,80% | 1,88% | 2027-03-31 | 700 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709TEV.P.F.N.II 21/27 | 4,00% | 99,37% | 3,75% | 2027-05-09 | 1,1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 2,53% | 97,00% | 0,25% | 2026-02-01 | 22,88 M USD | 1 000,00 USD | 1 000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| CCH33382750TEVA PH.FI.NL IV 16-25 | 2,34% | 98,68% | 1,00% | 2025-07-28 | 350 M CHF | 5 000,00 CHF | 5 000,00 CHF | Teva Pharmaceutical Finance Netherlands II BV |
| TT7AATEVA PH.F.NL.II 16/24 | 1,25% | 99,88% | 1,13% | 2024-10-15 | 626,919 M EUR | 1 000,00 EUR | 100 000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA3666246IVAX LLC 1.875% 15-DEC-2024 | — | — | 1,88% | 2024-12-15 | 333 M USD | 1 000,00 USD | 1 000,00 USD | IVAX LLC |